Renal cell carcinoma

Renal cell carcinoma

Definition:

Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type of kidney cancer in adults

Alternative Names:

Renal cancer; Kidney cancer; Hypernephroma; Adenocarcinoma of renal cells; Cancer - kidney

Causes, incidence, and risk factors:

Renal cell carcinoma affects about 3 in 10,000 people, resulting in about 31,000 new cases in the US per year. Every year, about 12,000 people in the US die from renal cell carcinoma. It is more common in men than women, usually affecting men older than 55.

Why the cells become cancerous is not known. A history of smoking greatly increases the risk for developing renal cell carcinoma. Some people may also have inherited an increased risk to develop renal cell carcinoma, and a family history of kidney cancer increases the risk.

People with von Hippel-Lindau disease, a hereditary disease that affects the capillaries of the brain, commonly also develop renal cell carcinoma. Kidney disorders that require dialysis for treatment also increase the risk for developing renal cell carcinoma.

The first symptom is usually blood in the urine. Sometimes both kidneys are involved. The cancer metastasizes (spreads) easily, most often to the lungs and other organs, and about one-third of patients have metastasis at the time of diagnosis.

Symptoms:

Blood in the urine
Abnormal urine color (dark, rusty, or brown)
Flank pain
Back pain
Abdominal pain
Weight loss, more than 5% of body weight
Emaciated, thin, malnourished appearance
Enlargement of one testicle
Swelling or enlargement of the abdomen

Additional symptoms that may be associated with this disease:

Signs and tests:

Palpation of the abdomen may show a mass or organ enlargement, particularly of the kidney or liver. There may be a testicular varicocele.

A CBC may show increased red blood cells (RBC) caused by stimulation of RBC production by the tumor. More commonly, though, it shows a decrease in RBC count.
The RBC in urine is increased.
Serum calcium levels may increase because of hormonal changes resulting from the tumor.
The SGPT and alkaline phosphatase may be elevated.
A urine cytology examination may show carcinoma cells.
Liver function tests may show involvement of the liver from metastasis, or may be abnormal without metastasis.
An ultrasound of the abdomen and kidney may show the tumor.
Kidney X-ray may indicate a tumor or calcification.
IVP may indicate obstruction by the tumor.
Renal arteriography may show the tumor if it is highly vascular.

Because metastasis is common, the following tests to look for metastasis may be performed:

An abdominal CT scan shows the kidney tumor and may show a liver mass.
Sometimes an abdominal MRI has to be done to determine if the tumor involves any surrounding blood vessels and to determine whether it can be surgically removed.
A chest X-ray may show mass in the chest.
A bone scan may show involvement of the bones.

Treatment:

Surgical removal of all or part of the kidney (nephrectomy) is recommended. This may include removal of the bladder or surrounding tissues or lymph nodes.

Radiation therapy is not commonly used for treatment of renal cell carcinoma because it is usually not successful. Hormone treatments may reduce the growth of the tumor in some cases.

Medications such as alpha-interferon and interleukin have been successful in reducing the growth of some renal cell carcinomas, including some with metastasis. Chemotherapy may be used in some cases, but cure is unlikely unless all the cancer can be removed with surgery.

Support Groups:

The stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group and kidney disease - support group.

Expectations (prognosis):

The outcome varies depending on the amount of metastasis. The 5-year survival rate is around 60% to 75% if the tumor is in the early stages and has not spread outside the kidney. If it has metastasized to the lymph nodes, the 5-year survival is around 5% to 15%. If it has spread to other organs, the 5-year survival at less than 5%.

Complications:

Hypertension
Metastasis (spread) of the cancer

Calling your health care provider:

Call your health care provider any time blood in the urine develops. Also call if any other symptoms of this disorder occur.

Prevention:

Minimize or stop smoking. Follow your health care provider's recommendations in the treatment of kidney disorders, especially those that may require dialysis.

Review Date: 8/3/2002
Reviewed By: Scott Howard, M.D., M.S., Memphis, TN. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.